PHILADELPHIA and LONDON, March 11 /PRNewswire/ --

- Industry Leader in Generic Market Information Offers Two New Solutions 
to Boost Competitive Advantage

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC)
and leading provider of information solutions to the worldwide research and
business communities, today announced the release of Newport Horizon Premium
and Newport Vision Premium, designed specifically for professionals working
in product selection, business development, competitive intelligence and API
(Active Pharmaceutical Ingredient) sourcing. Their use by innovator, generic
and OTC pharmaceutical companies and API manufacturers worldwide will enable
them to find the most appropriate product development opportunities more
quickly, and allow innovators to conduct deeper analysis on emerging generic
competition.

Newport Horizon Premium and Newport Vision Premium combine sales, launch,
patent, patent challenge, exclusivity, chemistry, prescribing and regulatory
information for more than 10,000 molecules, 18,000 companies, 67 markets and
90 patent countries worldwide with unique, early API development and
manufacturing intelligence. They build on the substantial success of Horizon
Global and Vision CI by adding kilogram and IU (International Units) API
consumption data from IMS Health to the data and capabilities already
available. This data will now be available for thousands of drugs by region
and by dose form for both the current and previous year and will allow
customers to evaluate scale, consumption trends and prices for active
ingredients, all of which can be difficult to estimate using sales data
alone.

"As the industry authority on the global generics market, we recognize
the need for authoritative generics market information that will give
customers a clear competitive advantage over their competitors," said Claude
Basset, vice president, PharmaChem Specialty Markets, Thomson Scientific. "We
developed Newport Horizon Premium and Newport Vision Premium to help
customers improve productivity, accelerate time to market, and gain that
competitive edge in the generics marketplace."

Both new solutions, Newport Horizon Premium and Newport Vision Premium
address the needs of large and small players in the pharmaceuticals market
and feature powerful multi-criteria search functionalities. Newport Horizon
Premium is aimed at helping generic, OTC and API companies in their constant
struggle to build deals faster and accelerate time to market. Newport Vision
Premium is focused on helping leading pharmaceutical companies evaluate the
earliest signs of generic competition for their brands and identify back-up
or alternative sources of API supply.

About The Thomson Corporation

The Thomson Corporation (www.thomson.com) is a global leader in providing
essential electronic workflow solutions to business and professional
customers. With operational headquarters in Stamford, Conn., Thomson provides
value-added information, software tools and applications to professionals in
the fields of law, tax, accounting, financial services, scientific research
and healthcare. The Corporation's common shares are listed on the New York
and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its
information solutions assist professionals at every stage of research and
development-from discovery to analysis to product development and
distribution. Thomson Scientific information solutions can be found at
scientific.thomson.com.

Web site: http://www.scientific.thomson.com
              http://www.thomson.com